Sign In

Login

Password

Forgot Password ? Sign Up

Metiltioanfetamina (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metiltioanfetamina" in Galician language version.

refsWebsite
Global rank Galician rank
12nih.gov
4th place
6th place
11doi.org
2nd place
7th place
2erowid.org
3,887th place
2,279th place
1ecstasy.org
low place
low place
1bbc.co.uk
8th place
31st place
1web.archive.org
1st place
1st place
1mpf.gov.ar
low place
low place

bbc.co.uk

news.bbc.co.uk

doi.org

dx.doi.org

  • Huang X, Marona-Lewicka D, Nichols DE (1992). "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.". Eur J Pharmacol 229 (1): 31–38. PMID 1473561. doi:10.1016/0014-2999(92)90282-9. 
  • Murphy, J; Flynn, JJ; Cannon, DM; Guiry, PJ; McCormack, P; Baird, AW; McBean, GJ; Keenan, AK (2002). "In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine.". European Journal of Pharmacology 444 (1–2): 61–7. PMID 12191583. doi:10.1016/S0014-2999(02)01586-8. 
  • Nutt, D; King, LA; Saulsbury, W; Blakemore, C (24 March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse.". Lancet 369 (9566): 1047–53. PMID 17382831. doi:10.1016/s0140-6736(07)60464-4. 
  • Elliott, SP (2000). "Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)". Journal of analytical toxicology 24 (2): 85–89. PMID 10732944. doi:10.1093/jat/24.2.85. 
  • De Letter, EA; Coopman, VA; Cordonnier, JA; Piette, MH (2001). "One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings". International journal of legal medicine 114 (6): 352–6. PMID 11508803. doi:10.1007/s004140100204. 
  • Decaestecker, T; De Letter, E; Clauwaert, K; Bouche, MP; Lambert, W; Van Bocxlaer, J; Piette, M; Van Den Eeckhout, E; Van Peteghem, C; De Leenheer, A (2001). "Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices". Journal of analytical toxicology 25 (8): 705–10. PMID 11765028. doi:10.1093/jat/25.8.705. 
  • Smets, G; Bronselaer, K; De Munnynck, K; De Feyter, K; Van De Voorde, W; Sabbe, M (2005). "Amphetamine toxicity in the emergency department". European Journal of Emergency Medicine 12 (4): 193–7. PMID 16034267. doi:10.1097/00063110-200508000-00010. 
  • Carmo, H; Remião, F; Carvalho, F; Fernandes, E; De Boer, D; Dos Reys, LA; De Lourdes Bastos, M (2003). "4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways". Toxicology and Applied Pharmacology 190 (3): 262–71. PMID 12902197. doi:10.1016/S0041-008X(03)00190-X. 
  • Hurtado-Guzmán, C; Fierro, A; Iturriaga-Vásquez, P; Sepúlveda-Boza, S; Cassels, BK; Reyes-Parada, M (2003). "Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine". Journal of enzyme inhibition and medicinal chemistry 18 (4): 339–47. PMID 14567549. doi:10.1080/1475636031000118437. 
  • Carmo, H.; Brulport, M.; Hermes, M.; Oesch, F.; De Boer, D.; Remião, F.; Carvalho, F. L.; Schön, M. R.; Krebsfaenger, N.; Doehmer, J.; Bastos Mde, M. D. L.; Hengstler, J. G. (2007). "CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)". Toxicology 229 (3): 236–244. PMID 17156908. doi:10.1016/j.tox.2006.10.024. 
  • Huang, X; Marona-Lewicka, D; Nichols, DE (1992). "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent". European Journal of Pharmacology 229 (1): 31–38. PMID 1473561. doi:10.1016/0014-2999(92)90282-9. 

ecstasy.org

erowid.org

mpf.gov.ar

nih.gov

ncbi.nlm.nih.gov

  • Huang X, Marona-Lewicka D, Nichols DE (1992). "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.". Eur J Pharmacol 229 (1): 31–38. PMID 1473561. doi:10.1016/0014-2999(92)90282-9. 
  • Li, Q; Murakami, I; Stall, S; Levy, AD; Brownfield, MS; Nichols, DE; Van De Kar, LD (1996). "Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).". The Journal of Pharmacology and Experimental Therapeutics 279 (3): 1261–7. PMID 8968349. 
  • Murphy, J; Flynn, JJ; Cannon, DM; Guiry, PJ; McCormack, P; Baird, AW; McBean, GJ; Keenan, AK (2002). "In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine.". European Journal of Pharmacology 444 (1–2): 61–7. PMID 12191583. doi:10.1016/S0014-2999(02)01586-8. 
  • Nutt, D; King, LA; Saulsbury, W; Blakemore, C (24 March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse.". Lancet 369 (9566): 1047–53. PMID 17382831. doi:10.1016/s0140-6736(07)60464-4. 
  • Elliott, SP (2000). "Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)". Journal of analytical toxicology 24 (2): 85–89. PMID 10732944. doi:10.1093/jat/24.2.85. 
  • De Letter, EA; Coopman, VA; Cordonnier, JA; Piette, MH (2001). "One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings". International journal of legal medicine 114 (6): 352–6. PMID 11508803. doi:10.1007/s004140100204. 
  • Decaestecker, T; De Letter, E; Clauwaert, K; Bouche, MP; Lambert, W; Van Bocxlaer, J; Piette, M; Van Den Eeckhout, E; Van Peteghem, C; De Leenheer, A (2001). "Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices". Journal of analytical toxicology 25 (8): 705–10. PMID 11765028. doi:10.1093/jat/25.8.705. 
  • Smets, G; Bronselaer, K; De Munnynck, K; De Feyter, K; Van De Voorde, W; Sabbe, M (2005). "Amphetamine toxicity in the emergency department". European Journal of Emergency Medicine 12 (4): 193–7. PMID 16034267. doi:10.1097/00063110-200508000-00010. 
  • Carmo, H; Remião, F; Carvalho, F; Fernandes, E; De Boer, D; Dos Reys, LA; De Lourdes Bastos, M (2003). "4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways". Toxicology and Applied Pharmacology 190 (3): 262–71. PMID 12902197. doi:10.1016/S0041-008X(03)00190-X. 
  • Hurtado-Guzmán, C; Fierro, A; Iturriaga-Vásquez, P; Sepúlveda-Boza, S; Cassels, BK; Reyes-Parada, M (2003). "Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine". Journal of enzyme inhibition and medicinal chemistry 18 (4): 339–47. PMID 14567549. doi:10.1080/1475636031000118437. 
  • Carmo, H.; Brulport, M.; Hermes, M.; Oesch, F.; De Boer, D.; Remião, F.; Carvalho, F. L.; Schön, M. R.; Krebsfaenger, N.; Doehmer, J.; Bastos Mde, M. D. L.; Hengstler, J. G. (2007). "CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)". Toxicology 229 (3): 236–244. PMID 17156908. doi:10.1016/j.tox.2006.10.024. 
  • Huang, X; Marona-Lewicka, D; Nichols, DE (1992). "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent". European Journal of Pharmacology 229 (1): 31–38. PMID 1473561. doi:10.1016/0014-2999(92)90282-9. 

web.archive.org